Immune Checkpoint Inhibitors Effective for Advanced Urothelial, Renal Cancers Immune Checkpoint Inhibitors Effective for Advanced Urothelial, Renal Cancers
In patients with advanced urothelial cell and renal cell cancers, immune checkpoint inhibitors (ICIs) are more effective and safer than conventional second-line treatment, a new systematic review from The Netherlands reports.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Kidney Cancer | Netherlands Health | Pathology | Renal Cell Carcinoma | Transitional Cell Carcinoma